Mv Capital Management, Inc. Bristol Myers Squibb CO Transaction History
Mv Capital Management, Inc.
- $889 Million
- Q1 2025
A detailed history of Mv Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mv Capital Management, Inc. holds 2,643 shares of BMY stock, worth $132,678. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,643
Previous 3,155
16.23%
Holding current value
$132,678
Previous $178,000
9.55%
% of portfolio
0.02%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding BMY
# of Institutions
2,780Shares Held
1.56BCall Options Held
27.9MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.54 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.96 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.82 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.78 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.03 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...